Premium
The role of β‐blockers in dermatological treatment: a review
Author(s) -
Chen L.,
Tsai T.F.
Publication year - 2018
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/jdv.14566
Subject(s) - medicine , dermatology , intensive care medicine
Many systemic medications have been used off‐label in cutaneous diseases. Use of β‐adrenergic‐blocking agents has risen in popularity among dermatologists since the discovery of their efficacy in treating infantile haemangioma. There has also been an increase in the interest of the applications of β‐blockers in other skin disorders. Overall, β‐blockers are effective in treating diseases of vascular origin and promote wound healing. They are relatively safe and inexpensive medications that could be included in the armamentarium against skin diseases.